Synergetic effect between interleukin-1 receptor antagonist allele (IL1RN*2) and MHC class II (DR17,DQ2) in determining susceptibility to systemic lupus erythematosus

Abstract

We investigated whether IL1RN alleles separately or in combination with MHC class II variants, contribute to susceptibility to SLE and to analysed if IL1RN alleles are markers of disease severity.

We investigated 81 patients from a defined area in southern Sweden diagnosed between 1981–1992 and 10 consecutive Caucasian families with multiple cases of SLE. As control group 189 healthy blood donors was used. PCR amplification of defined gene sequences was used in determining the IL1RN polymorphism as well as the MHC class II variants. The IL-1RA levels were measured by an immunoassay.

We found an increased frequency of IL1RN*2 in both the epidemiological cohort and in the multicase families (P < 0.01). Alone IL1RN*2 and MHC class II (DR17,DQ2) separately increased the SLE risk moderately. The occurrence of IL1RN*2 and MHC class II variants DR17 and DQ2 together increased the risk to develop SLE by a sevenfold. The IL-1RA gene polymorphism did not correlate with disease severity or with renal involvement. We found an association between IL1RN*1 and arthritis (P < 0.001). Serum level of IL-1RA did not correspond to any specific IL1RN allele.

An increased frequency of IL1RN*2 suggests the presence of a gene, implemented in SLE-susceptibility, in the IL1RN region of chromosome 2. IL1RN*2 and specific variants of MHC class II act in synergy to increase disease susceptibility. IL1RN*1 may be a marker of risk for development of arthritis.

Keywords

SLE MHC IL-1RA genetics microsatellite

Get full access to this article

View all access options for this article.

References

Dayer J-M , Arend WP . Cytokines and growth factors. In: Kelley WN , Harris ED , Ruddy S , Sledge CB (eds). Textbook of Rheumatology. WB Saunders: Philadelphia , 1997, pp 267–286.

Weckmann AL , Alcocer-Varela J . Cytokine inhibitors in autoimmune disease . Sem Arthritis Rheum 1996; 26: 539–557 .

Tarlow JK et al. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by a variable numbers of an 86-bp tandem repeat . Hum Genet 1993; 91: 403–404 .

Blakemore AIF et al. Interleukin-1 receptor antagonist allele (IL1RN*2) associated with nephropathy in diabetes mellitus . Hum Genet 1996; 97: 369–374 .

Mansfield JC et al. Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist . Gastroenterology 1994; 106: 637–642 .

Bioque G et al. Evidence of genetic heterogeneity in IBD: 1. The interleukin-1 receptor antagonist in the predisposition to suffer from ulcerative colitis . Eur J Gastroenterol Hepatol 1996; 8: 105–110 .

Clay FE et al. Novel interleukin-1 receptor antagonist exon polymorphisms and their use in allele-specific mRNA assessment . Hum Genet 1996; 97: 723–726 .

Truedsson L et al. Sharing of MHC haplotypes among patients with Systemic Lupus Erythematosus from unrelated Caucasian multicase families: disease association with the extended haplotype [HLAB8,SC01,DR17] . J Rheumatol 1995; 22: 1852–1861 .

Mehrian R et al. Synergistic effect between IL-10 and bcl-2 genotypes in determining susceptibility to systemic lupus erythematosus . Arthritis Rheum 1998; 41: 596–602 .

10.

Sturfelt G , Roux-Lombard O , Wollheim FA , Dayer J-M . Low levels of interleukin-1 receptor antagonist coincide with kidney involvement in Systemic Lupus Erythematosus . Br J Rheumatol 1997; 36: 1283–1289 .

11.

Suzuki H , Takemura H , Kashiwagi H . Interleukin-1 receptor antagonist in patients with active Systemic Lupus Erythematosus . Arthritis Rheum 1995; 38: 1055–1059 .

12.

Hsieh S-C et al. Defective spontaneous and bacterial lipopolysaccharide-stimulated production of interleukin-1 receptor antagonist by Polymorphonuclear neutrophils of patients with active Systemic Lupus Erythematosus . Br J Rheumatol 1995; 34: 107–112 .

13.

Blakemore AIF et al. Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in Systemic Lupus Erythematosus . Arthritis Rheum 1994; 37: 1380–1385 .

14.

Danis VA , Millington M , Hyland VJ , Grennani D . Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism . Clin Exp Immunol 1995; 99: 303–310 .

15.

Santtila S , Savinainen K , Hurme M . Presence of the IL-1RA Allele 2 (IL1RN*2) is associated with enhanced IL-1b production in vitro . Scand J Immunol 1998; 47: 195–198 .

16.

Jonsson H , Nived O , Sturfelt G . Outcome in Systemic Lupus erythematosus: A prospective study of patients from a defined population . Medicine 1989; 68: 141–150 .

17.

Tan EL et al. The 1982 revised criteria for the classification of Systemic Lupus Erythematosus . Arthritis Rheum 1982; 25: 1271–1277 .

18.

Gladman D et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for Systemic Lupus Erythematosus . Arthritis Rheum 1996; 39: 363–369 .

19.

Sambrook J , Fritsch EF , Maniatis T . Molecular Cloning , 2nd edn. Cold Spring Harbor Laboratory: New York , 1989, pp 9.16–9.19.

20.

Miller SA , Dykes DD , Polesky HF . A simple salting out procedure for extracting DNA from human nucleated cells . Nucl Acids Res 1988; 16: 1215–1225 .

21.

Olerup O , Zetterquist H . HLA-DR typing in PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor–recipient matching in cadaveric transplantation . Tissue Antigens 1992; 39: 225–235 .

22.

Olerup O , Zetterquist H . DR ‘low resolution’ PCR-SSP typing<Eth>a correction and an up-date . Tissue Antigens 1993; 41: 55–56 .

23.

Aldener-Cannavá A , Olerup O . HLA-DQB1 ‘low-resolution’ typing by PCR amplification with sequence-specific primers (PCR-SSP) . Eur J Immunogenetics 1994; 21: 447–455 .

24.

Bombardier C et al. Derivation of the SLEDAI . Arthritis Rheum 1992; 35: 630–640 .

25.

Winchester R . Genetic susceptibility to Systemic Lupus Erythematosus. In: Lahita RG (ed). Systemic Lupus Erythematosus. Churchill Livingstone: New York , 1991, pp 65–85.

26.

Lewkonia RM . The clinical genetics of Lupus . Lupus 1992; 1: 55–62 .